Liposomal Amphotericin B: Uses, Dosage & Side Effects Explained

Summary of Key Points

Amphotericin B liposomal is a highly effective antifungal medication designed to treat severe fungal infections, including candidiasis, aspergillosis, and cryptococcosis. This specialized liposomal formulation targets the fungal cell membrane, ultimately destroying the fungus. Due to its strength, it is typically reserved for serious infections and is administered intravenously under medical supervision. Always consult your healthcare provider before starting or modifying antifungal treatment. If you have questions about liposomal amphotericin B or other antifungal therapies, our telemedicine providers are here to assist you.

Names of the Medication

US Brand Name: AmBisome

Generic Name: Amphotericin B liposomal

The generic name, Amphotericin B liposomal, refers to the active ingredient, while the brand name, AmBisome, is the name given by the manufacturer. This liposomal drug delivery system enhances the medication’s effectiveness while reducing its potential toxicity, making it a safer option for treating severe infections.

Pharmacologic Category

Category: Antifungal Agent

Type: Polyene Antifungal

Dosing Guidelines for Amphotericin B Liposomal

The appropriate dosage of liposomal amphotericin B depends on the type and severity of the fungal infection being treated. Below are common conditions and their corresponding dosing recommendations. Always consult your healthcare provider before making any changes to your prescribed dose. For personalized advice, you can schedule a telemedicine appointment with one of our providers.

1. Candidiasis: 3-5 mg/kg/day IV for 14 days or until clinical improvement is observed.
2. Aspergillosis: 3-5 mg/kg/day IV for at least 14 days, depending on the severity of the infection.
3. Cryptococcosis: 3-4 mg/kg/day IV for 6-10 weeks, based on the patient’s response to treatment.
4. Mucormycosis: 5 mg/kg/day IV for 6-8 weeks or longer, depending on the severity of the infection.
5. Histoplasmosis: 3 mg/kg/day IV for 4-6 weeks, followed by oral antifungal therapy to complete treatment.
6. Blastomycosis: 3-5 mg/kg/day IV for 6-12 weeks, depending on the severity of the condition.
7. Leishmaniasis: 3 mg/kg/day IV for 5 days, with a second course administered after 10 days if necessary.
8. Coccidioidomycosis: 3-5 mg/kg/day IV for 6-12 weeks, depending on the severity of the infection.
9. Fusariosis: 3-5 mg/kg/day IV for 6-12 weeks or longer, depending on the patient’s clinical response.
10. Zygomycosis: 5 mg/kg/day IV for 6-8 weeks or longer, based on the severity of the condition.

Dosage Forms and Strengths

Injection, Intravenous: 50 mg per vial

Administration Instructions

Amphotericin B liposomal is administered through intravenous (IV) infusion, typically in a hospital or clinical setting. The infusion is given slowly over a period of two hours or more to help minimize potential side effects. It is important to follow your healthcare provider’s instructions carefully. If you experience any discomfort during the infusion, notify your healthcare provider immediately. For additional support, our telemedicine team is available to help manage your treatment with liposomal amphotericin B.

Adverse Reactions and Side Effects

As with any medication, liposomal amphotericin B may cause side effects. While some are relatively common and manageable, others are rare but potentially serious. It is important to discuss any side effects with your healthcare provider to ensure proper management.

Common Side Effects

1. Fever and chills: These symptoms may occur during or shortly after the infusion.
2. Nausea and vomiting: Some patients may experience an upset stomach.
3. Headache: Mild to moderate headaches are possible.

Serious Side Effects

1. Kidney damage: Amphotericin B can impact kidney function, so regular monitoring is essential during treatment.
2. Low potassium levels: This can lead to muscle weakness and irregular heart rhythms.
3. Allergic reactions: Symptoms may include swelling, difficulty breathing, or the appearance of a rash.

Contraindications for Amphotericin B Liposomal

A contraindication refers to a specific condition or circumstance in which a medication, such as Amphotericin B liposomal, should not be used because it may cause harm. Recognizing these contraindications is crucial to avoid serious side effects or complications. Below are the primary contraindications for using liposomal amphotericin B:

Allergy to Amphotericin B or its components: If you have a known allergy to Amphotericin B or any ingredient in its liposomal formulation, taking this antifungal medication could result in a severe allergic reaction, including potentially life-threatening anaphylaxis.

Severe kidney impairment:Liposomal amphotericin B is known to be nephrotoxic, meaning it can harm the kidneys. If you have significant pre-existing kidney disease, this medication may exacerbate your condition. Your healthcare provider will evaluate your kidney function before prescribing this antifungal treatment.

Electrolyte imbalances (low potassium or magnesium levels):Amphotericin B liposomal can cause or worsen hypokalemia (low potassium) and hypomagnesemia (low magnesium), which may lead to serious heart rhythm disturbances. These imbalances should be corrected prior to starting treatment.

Drug-to-Drug Interactions with Amphotericin B Liposomal

Amphotericin B liposomal can interact with other medications, potentially increasing the risk of side effects or diminishing the effectiveness of one or both drugs. Below are some significant drug interactions to be aware of when using this liposomal antifungal medication:

1. Cyclosporine (Neoral, Sandimmune): This immunosuppressant may heighten the risk of kidney damage when used alongside Amphotericin B liposomal.
2. Digoxin (Lanoxin):Liposomal amphotericin B can lower potassium levels, increasing the likelihood of digoxin toxicity.
3. Corticosteroids (Prednisone, Dexamethasone): These medications can also reduce potassium levels, amplifying the risk of dangerous heart rhythm abnormalities when combined with liposomal amphotericin B.
4. Furosemide (Lasix): This diuretic may further deplete potassium and magnesium levels, raising the risk of severe electrolyte imbalances.
5. Other antifungal medications (Fluconazole, Itraconazole): Using Amphotericin B in combination with other antifungal treatments may increase the likelihood of side effects, including kidney damage.

Amphotericin B Liposomal in Pregnancy

Is it safe to take Amphotericin B liposomal during pregnancy?

Amphotericin B liposomal is classified as a Category B medication for pregnancy. This designation indicates that animal studies have not demonstrated harm to the fetus, but there are no well-controlled studies in pregnant women. In cases of severe fungal infections, the potential benefits of using liposomal amphotericin B may outweigh the possible risks to the fetus. If you are pregnant or planning to become pregnant, consult your healthcare provider to carefully weigh the risks and benefits of this antifungal treatment.

Amphotericin B Liposomal While Breastfeeding

Is it safe to use Amphotericin B liposomal while breastfeeding?

There is limited information available regarding the safety of Amphotericin B liposomal during breastfeeding. It is not yet clear whether this liposomal formulation of Amphotericin B passes into breast milk. However, because Amphotericin B is poorly absorbed through the gastrointestinal tract, it is unlikely to pose a risk to a nursing infant. Even so, it is essential to discuss potential risks and benefits with your healthcare provider before using this antifungal medication while breastfeeding.

Estimated Cost of Amphotericin B Liposomal

The cost of a 30-day supply of Amphotericin B liposomal without insurance can vary significantly. With a GoodRX coupon, prices typically range from $1,500 to $3,000. These costs may differ depending on the pharmacy and your location. To ensure you have the most accurate and up-to-date pricing, consider checking GoodRX or similar discount programs regularly.

Possible Alternatives to Amphotericin B Liposomal

If Amphotericin B liposomal is not the right option for your antifungal treatment, there are several alternatives available, depending on the type of fungal infection. It is crucial to consult your healthcare provider before making any changes to your treatment plan. If needed, you can also schedule a telemedicine appointment with one of our providers to explore your options further.

Alternative Antifungal Treatments by Infection Type

1. Candidiasis: Alternatives include Fluconazole (Diflucan) or Itraconazole (Sporanox). For localized infections, topical antifungal creams may be sufficient.
2. Aspergillosis: Voriconazole (Vfend) is often the first-line treatment, with Isavuconazole (Cresemba) as another effective option.
3. Cryptococcosis: Fluconazole (Diflucan) is commonly used, particularly for maintenance therapy following initial treatment with Amphotericin B.
4. Mucormycosis: Posaconazole (Noxafil) or Isavuconazole (Cresemba) may be viable alternatives.
5. Histoplasmosis: Itraconazole (Sporanox) is typically recommended for mild to moderate cases, while severe cases may still require Amphotericin B.
6. Blastomycosis: Itraconazole (Sporanox) is often used for mild to moderate infections, while severe cases may necessitate Amphotericin B.
7. Leishmaniasis: Sodium stibogluconate or Miltefosine (Impavido) are alternative treatments for this parasitic infection.
8. Coccidioidomycosis: Fluconazole (Diflucan) or Itraconazole (Sporanox) are frequently used as alternatives.
9. Fusariosis: Voriconazole (Vfend) or Posaconazole (Noxafil) may be considered as alternative treatments.
10. Zygomycosis: Posaconazole (Noxafil) or Isavuconazole (Cresemba) are potential alternatives.

Recent Updates on Amphotericin B Liposomal Research

Recent advancements in Amphotericin B liposomal research have focused on improving its safety profile, particularly by addressing kidney toxicity, a common side effect of this medication. Scientists are working on new formulations and enhanced liposomal drug delivery systems to reduce adverse effects while preserving its effectiveness against severe fungal infections.

Additionally, ongoing studies are exploring the use of Amphotericin B liposomal in combination with other antifungal agents to improve outcomes for drug-resistant fungal infections. Researchers are also investigating its long-term effects in immunocompromised patients, such as those living with HIV or undergoing chemotherapy.

Staying informed about these developments is important. If you have questions about how recent research might influence your treatment, consider scheduling a telemedicine appointment with one of our healthcare providers to discuss your options in detail.

James Kingsley

Learn More